Aurora Cannabis (ACB) EBIT (2018 - 2025)
Historic EBIT for Aurora Cannabis (ACB) over the last 8 years, with Q4 2025 value amounting to $14.0 million.
- Aurora Cannabis' EBIT fell 4682.29% to $14.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.1 million, marking a year-over-year decrease of 10486.97%. This contributed to the annual value of $3.4 million for FY2025, which is 11030.28% up from last year.
- Latest data reveals that Aurora Cannabis reported EBIT of $14.0 million as of Q4 2025, which was down 4682.29% from $2.4 million recorded in Q3 2025.
- In the past 5 years, Aurora Cannabis' EBIT ranged from a high of $26.4 million in Q4 2024 and a low of -$112.9 million during Q1 2021
- For the 5-year period, Aurora Cannabis' EBIT averaged around -$21.7 million, with its median value being -$11.8 million (2023).
- In the last 5 years, Aurora Cannabis' EBIT soared by 30412.82% in 2024 and then tumbled by 89891.83% in 2025.
- Over the past 5 years, Aurora Cannabis' EBIT (Quarter) stood at -$44.3 million in 2021, then fell by 11.43% to -$49.3 million in 2022, then skyrocketed by 73.79% to -$12.9 million in 2023, then soared by 304.13% to $26.4 million in 2024, then plummeted by 46.82% to $14.0 million in 2025.
- Its last three reported values are $14.0 million in Q4 2025, $2.4 million for Q3 2025, and -$749137.6 during Q2 2025.